REMTOLUMAB

UNII:	1V8WRH3RVX
Formula:
Preferred Substance Name:	REMTOLUMAB

1791410-27-9
A-1230717
ABT-122
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), HOMO SAPIENS MONOCLONAL ANTIBODY, TETRAVALENT BISPECIFIC GAMMA1 HEAVY CHAIN (1-587) (HOMO SAPIENS VH ANTI-TNF (IGHV3-9*01 (93.90%) -(IGHD) -IGHJ4*01) (8.8.14) (1- 121) -10-MER BIS(TETRAGLYCYL-SERYL) LINKER (122-132) -HOMO SAPIENS VH ANTI-IL17A (IGHV1-69*01 (85.70%) -(IGHD) - IGHJ6*01) (8.8.19) (132-257) -IGHG1*01, G1M17,1 (CH1 (258-355), HINGE (356-370), CH2 (371-480), CH3 (481- 585), CHS (586-587)) (258-587)), (360-331')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-331') (HOMO SAPIENS V-KAPPA ANTI- TNF (IGKV1-27*01 (95.80%) -IGKJ2*01) (6.3.9) (1'-107') - HOMO SAPIENS V-KAPPA ANTI-IL17A (IGKV6-21*01 (90.50%) -IGKJ3*01) (6.3.9) (118'-224') -IGKC*01, KM3 (225'-213'))DIMER (366-366'':369-369'')-BISDISULFIDE IMMUNOMODULATOR
IMMUNOGLOBULIN, ANTI-(TUMOR NECROSIS FACTOR .ALPHA./INTERLEUKIN 17) (SYNTHETIC HUMAN A-1230717 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN A-1230717 LIGHT CHAIN, DIMER
REMTOLUMAB [INN]
REMTOLUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

REMTOLUMAB

Synonyms and Mappings

Resources